Bacterial Infections and Mycoses
11
0
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.1%
1 terminated out of 11 trials
88.9%
+2.4% vs benchmark
45%
5 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Metagenomic Sequencing in Clinical Infectious Diseases
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure
Infant Antibiotic Resistance and Implications for Therapeutic Decision-making
Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants
Iron Homoeostasis in Inflammation
A Study in Sepsis Patients With Renal Failure
Doripenem in the Treatment of Complicated Intra-Abdominal Infections
Doripenem in the Treatment of Complicated Intra-Abdominal Infections
Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients